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Vesicles that do not contain spectrin were released from human erythrocytes by incubation with dimyristoylphosphatidylcholine. The transbilayer 
orientation of membrane phospholipids was subsequently determined by two independent methods. Incubation with phospholipase A 2 revealed 
that the phospholipid asymmetry observed in red blood cells was essentially preserved in vesicles. By use of the prothrombinase assay a still highly 
asymmetric distribution of phosphatidylserine could be demonstrated in spite of its slightly increased exposure on the vesicle surface. These results 
show that membrane phospholipid asymmetry can be maintained in a system that does not contain an intact membrane skeleton or spectrin. 
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1. INTRODUCTION 
Red blood cell membranes, as well many other cell 
membranes, have their phospholipids distributed asym- 
metrically over both leaflets of the bilayer. Whereas the 
aminophospholipids phosphatidylethanolamine and 
phosphatidylserine are primarily located at the cyto- 
plasmic side, the choline-containing phospholipids 
phosphatidylcholine and sphingomyelin are mainly 
present at the exterior side of the cell membrane [1-3]. 
Asymmetry is maintained in spite of a transbilayer 
movement of some of these phospholipids which is rela- 
tively fast with respect o the red cell life span. Hence, 
lipid asymmetry must be maintained by processes that 
counteract such a tong-term randomization. 
An ATP-dependent aminophospholipid translocase, 
that selectively transports the aminophospholipids from 
the outer to the inner monolayer, has been claimed to 
be able to generate and maintain phospholipid asymme- 
try (for review, see [4]). Alternatively, it has been pro- 
posed that interactions between aminophospholipids 
and the membrane skeleton (in particular spectrin and 
band 4.1) also participate in supporting phospholipid 
asymmetry. Such interactions have indeed been shown 
to occur [5-7] but do not appear to be strong enough 
to explain lipid asymmetry sufficiently [8]. A study with 
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erythrocytes from sickle cell patients suggested that 
both the aminophospholipid translocase and the mem- 
brane skeleton are required [9]. However, recent studies 
have indicated that the glycerophospholipid distribu- 
tion remained essentially unaffected in erythrocytes 
where spectrin was heat denatured [10] or in cells that 
were partially spectrin-deficient [11], suggesting that 
this component of the membrane skeleton cannot be the 
major responsible factor for maintaining transbilayer 
phospholipid asymmetry. 
An approach to examine the importance of the com- 
ponents of the membrane skeleton in preserving phos- 
pholipid asymmetry is to prepare and study erythrocyte 
membrane fragments that lack (parts of) the membrane 
skeleton. In fact, erythrocytes release membrane vesi- 
cles under a variety of conditions and different methods 
to generate these structures in vitro have been de- 
scribed. So far, determinations of phospholipid asym- 
metry in these microvesicles have revealed controversial 
results: in some types of vesicles asymmetry appeared 
to be preserved [12,13], whereas in others complete 
scrambling of the phospholipids was observed [14,15]. 
The vesicles released upon incubation of red blood 
cells with dimyristoylphosphatidylcholine (DMPC) [16] 
contain intrinsic membrane proteins but are essentially 
devoid of spectrin and other elements of the membrane 
skeleton [17]. Their phospholipid composition is almost 
identical to the one observed in intact erythrocytes [16]. 
Recently it was shown that the DMPC-induced vesicles 
contain an ATP-dependent aminophospholipid translo- 
case activity [18], but the steady-state distribution of the 
endogenous phospholipids has not yet been character- 
ized. 
In the present study, DMPC-induced vesicles were 
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used as a model system to examine the orientation of 
endogenous red cell phospholipids in the absence of an 
intact membrane skeleton. Phospholipase A2 and the 
prothrombinase assay were applied for characterization 
of asymmetry. The results how that, in spite of a slight 
destabilization f the membrane, the asymmetric distri- 
bution of phospholipids observed in the red blood cell 
membrane is essentially preserved in the vesicles. 
2. MATERIALS AND METHODS 
2.1. Materials 
Phospbolipase A2 (EC 3.1.1.4) from bee venom (Sigma USA) was 
dissolved in 100 mM TRIS-HCI, 5 mM CaCI2, pH 7.8, 50% glycerol 
(v/v) to a concentration f 5 IU/ktl, stored at -20°C and used without 
further purification. 
Purified prothrombin, factor Va and factor Xa were supplied by Dr. 
R. Wagenvoord, University of Limburg, the Netherlands. The chro- 
mogenic substrate $2238 was obtained from Chromogenix AB, 
M61ndal, Sweden. 
All other eagents used were obtained either from Merck, Fluka or 
Sigma, and of the highest grade available. 
2.2. Erythrocytes 
Erythrocytes were obtained from the ZLB Central Laboratory 
Blood Transfusion Service SRC (Bern, Switzerland), stored at 4°C 
and used within 3 days. The cells were washed at least 3 times with 
isotonic buffer by centrifugation at 1,000 x g for 7 min. After each 
wash the supernatant and rest of the buffy coat were removed carefully 
by aspiration. 
2.3. Vesicle preparation 
DMPC-induced vesicles were prepared and purified as described 
elsewhere [18]. Briefly, freshly washed erythrocytes were incubated in 
a buffer containing 10 mM TRIS-HCI, 144 mM NaCI, 0.5 mM ade- 
nine, 10 mM glucose, 1 mM EDTA, 2 x 105 U/I Penicillin, 1.5 x 105 
U/1 Streptomycin, pH 7.4, for 4.5 h at 30°C in presence of small 
unilamellar DMPC-vesicles. After separation from the remnant cells 
by centrifugation at 1,000 x g, the released crude vesicles were pelleted 
at 34,500 x g and resuspended in buffer A (10 mM HEPES, t44 mM 
NaCI, pH 7.4) for subsequent purification on a Sephacryl S-1000 
superfine (Pharmacia Fine Chemicals) column. After purification the 
vesicles were stored overnight at 4°C in buffer A. 
Yield and recovery of vesicles during the preparation procedure 
were routinely controlled by determination f the membrane marker 
enzyme acetylcholinesterase (ACHE), measured according to Ellmann 
et al. [19]. To control the permeability of the vesicle membranes, the 
cytoplasmic enzyme adenylate kinase was used as a marker. Its activity 
was measured essentially as described by Beleznay et al. [18], by fol- 
lowing the time course of ATP production. Vesicle integrity was ex- 
pressed as the percent ratio of the activities measured in the absence 
and presence of 0.01% (v/v) Triton X-100. The relative amount of 
leaky vesicles did not exceed 23% (1.41% _+ 0.43, n = 10). The total 
ATP content of the vesicles, determined as described by Beleznay et 
al. [18], was found to be I1.0 _+ 5.4 ¢tM ATP per mM Hgb (n - il), 
which is 14% of the average value in intact red cells (80 -+ 17 ¢tM 
ATP/mM Hgb, n = 26). 
2.4. Phospholipase A 2 assay 
2.4.1. Erythrocytes 
Freshly washed red blood cells were resuspended in buffer B (25 
mM TRIS-HCI, 30 mM NaCI, 90 mM KC1, 1 mM MgCI2, 5 mM 
CaCI,_, and 40 mM sucrose, pH 7.8) at a hemat~erit of about 8%, 
equivalent to a phospholipid concentration f 0.35 mM. After addi- 
tion of 10 IU/ml bee venom PLA 2 the cells were incubated ina rotary 
shaking waterbath at 110 rpm for 1 h at 37°C. The incubation was 
stopped by addition of EDTA (pH 7.8) to a final concentration f 10 
raM. Aliquots of 2.5 ml were taken for lipid extraction, and hemolysis 
was estimated by comparing the haemoglobin concentration (meas- 
ured at 418 nm) of a 1,000 x g supernatant toan equivalent amount 
of cell hemolysate. Control ipid extracts were made from cell suspen- 
sions that had not been exposed to PLA2. 
2.4.2. Ghosts 
Open white ghosts were prepared according to Gratzer [20], resus- 
pended in buffer B at a concentration f 0.3 mM total phospholipid 
and incubated with bee venom PLA2 as described for erythrocytes. 
2.4.3. Vesicles 
Vesicles were pelleted by centrifugation at 34,500 x g for 30 min, 
and resuspended in buffer B to a final concentration corresponding 
to approximately 1.8 IU AChE/ml, equivalent to a concentration f 
total phospholipid n the range of 0.29 to 0.35 mM. PLA a from bee 
venom was added to a final concentration f 12 IU/ml and the suspen- 
sions with a volume of 3 ml were incubated for increasing time inter- 
vals at 37°C in a rotary shaking waterbath at 110 rpm. The incubation 
was stopped by addition of EDTA (pH 7.8) to a final concentration 
of 10 mM. Control vesicles were incubated in absence of PLA2. 
Aliquots of 0.5 ml were taken for characterization f vesicle integ- 
rity, and kept on ice until used. The remaining incubated suspension 
was used for lipid extraction. 
2.5. Vesicle integrity 
To characterize v sicle integrity after incubation with PLA 2, haemo- 
globin was used as a cytoplasmic marker protein. The relative amount 
of leaky vesicles was calculated by comparing the haemoglobin con- 
centration i  supernatants and vesicle lysates, measured photometri- 
cally using a Molecular Devices Vmax Kinetic Microplate Reader. 
Supernatants were obtained by centrifngation f a 180 ,ul aliquot of 
vesicle suspension for 1 min at 200,000 x g using a Beckman Airfuge 
Air-Driven Ultracentrifuge. To obtain a vesicle lysate, 500 ktl of unin- 
cubated vesicle suspension was mixed with 20/11 of an 1% (v/v) Triton 
X-10G solution (corresponding to the volume of EDTA added after 
PLA~ incubation) to yield a final concentration f 0.04% (v/v) Triton 
X-100. This lysate was further diluted in the range from 5- to 100-fold 
with buffer B. 
2.6. Phospholipid etermination 
Lipids were extracted from erythrocyte suspensions according to the 
method of Rose and Oklander [21], and from vesicle and ghost suspen- 
sions according to the method of Bligh and Dyer [22]. 
Total phospholipid was quantified by measuring the phospholipid 
phosphorus according to Rouser et al. [23]. Cholesterol was measured 
according to Ott et al. [24], using the Monotest for cholesterol 
(Boebringer Mannheim) with the reagent reconstituted in 0.5% Triton 
X-100. 
Phospholipids were separated by two-dimensional thin layer chrom- 
atography according to the method of Broekhuyse [25] using predried 
silica gel plates (200 by 200 mm; Merck), which were first developed 
in chloroform/methanol/2: 7o ammonia/water (90:54:5.5:5.5, by vol- 
ume), followed by drying and subsequent development i  the second 
direction in chlor~,(orm/methanol/acetic acid/water (90:40:12:2, by 
volume). The individual phospholipid spots were detected by iodine 
vapour and ninhydrin spray (1% ninhydrin in acetone), scraped off 
and the phospholipid content of each spot was quantified by measur- 
ing the phospholipid phosphorus according to Rouser et al. [23]. 
2.7. Determination of procoagulant activity (prothrombinase assay) 
The rate of thrombin formation promoted by red blood cells and 
vesicles was assayed essentially as described by Bevers et al. [26] in a 
system including purified coagulation factors Xa and Va, prothrombin 
and a chromogenic substrate specific for thrombin. 
A 30/zl aliquot of vesicle or cell suspension (equivalent to a maxi- 
mum of O. 18 and 0.38 mM total phospholipid, respectively) was added 
to 295~ul of a buffer containing t0 mM TRIS-HCI, 136 mM NaC1, 2.7 
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mM KC1, 4 mM CaC12 and 0.5 mg/ml HSA at pH 7.9. Factors Va and 
Xa were added and the suspension was incubated for 2 rain at 37°C 
prior to addition of a prewarmed prothrombin solution containing 5.6 
mM CaCIz and 0.5 mg/ml HSA. Final concentrations i  the reaction 
mixture (total 500 ,ul) were: 3 nM factor Xa, 6 nM factor Va, 4 pM 
prothrombin, 4 mM CaC12, and 0.5 mg/ml HSA. 
At timed intervals, aliquots of 25 pl were taken from the incubation 
mixture and transferred to disposable cuvets containing 1ml buffer 
(50 mM TRIS-HCI, 120 mM NaCl, 2 mM EDTA, pH 7.5) to stop the 
thrombin formation. A volume of 75 ~tl of the thrombin specific 
chromogenic substrate S2238 (2.2 raM) was added (final concentra- 
tion 150 ¢tM) and from the rate of absorbance hange at 405 nm the 
concentration f thrombin was calculated. 
To obtain a reference prothrombinase activity in presence of red cell 
membrane phospholipids, the assay was performed on cell and vesicle 
suspensions that had been sonicated for 10 min using a Branson tip 
sonifier (70 W, duty cycle 50%) at a phospholipid concentration f a 
maximum of 5 ,uM. 
3. RESULTS 
3.1. Lipid composition 
Table I shows that the phospholipid compositions of
red blood cells and vesicles are very similar with the 
exception of a somewhat increased content in PC that 
is found in the vesicles as a result of the incubation with 
DMPC. The fraction of DMPC was calculated to be 
approximately 30% of the total PC pool of the vesicles 
(13% of total vesicle phospholipid) by expressing the 
amounts of the glycerophospholipids relative to the 
amount of SM. This is in agreement with earlier esults 
[161. 
The cholesterol to phospholipid molar ratio was 
found to be decreased in the vesicles to 0.59 + 0.10 
(n = 20) compared to 0.76 + 0.06 (n = 15) in red blood 
cells. 
3.2. Lipid degradation 
3.2.1. Intact vesicles 
The time course of the degradation of vesicle 
phospholipids by bee venom PLA2 is summarized in 
Fig. 1. The data shown are expressed as reduction i  the 
amount of undegraded phospholipid. Plateau levels of 
PC and PE degradation were calculated by fitting the 
degradation data to single exponential decay curves 
which resulted in a value of 56.8% for PC and of 7.6% 
Table I 
Phospholipid composition ofred blood cells and DMPC-induced ves- 
icles, expressed as percent of total phospholipid 
Phospholipid Cells (%) Vesicles (%) 
PC 32.8 + 1.9 40.7 _+ 1.9 
PE 25.7 _+ 2.9 22.6 _+ 0.9 
PS 11.4_+ 1.1 11.4_+ 0.8 
SM 28.1 + 2.0 23.7 _+ 1.4 
PA 1.8 _+ 0.5 1.7 + 0.5 
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Fig. 1. Time course of phospholipid egradation i intact DMPC- 
induced vesicles. Phospholipase incubations were carried out as de- 
scribed in Section 2. The plots show the results for the degradations 
of PC (panel A), PE (panel B), and PS (panel C). The error bars reflect 
the range of results obtained from multiple measurements (up to 5) 
performed in 2 independent experiments. For PC and PE, the calcu- 
lated plateau levels are indicated in the plots as dashed lines. 
for PE. A calculation based on the relative amounts of 
the degradation product and the undegraded phospho- 
lipid gave a plateau value of 55.5% for PC and 10.6% 
for PE (corrected for the amount of lysophospholipid 
present in untreated vesicles). The relative amounts of 
total PC and SM remained constant during the incuba- 
tion, whereas the relative amount of PE appeared to 
increase slightly (data not shown). 
For the degradation of PS it was not possible to 
obtain an accurate curve fit, because of the very small 
decrease in the amount of this phospholipid that was 
observed uring the incubation. The relative amount of 
PS that was degraded after a one hour incubation pe- 
riod could be estimated to be approximately 4--5%. 
Moreover, PS degradation could not be calculated from 
the lysophospholipid formed uring the incubation, be- 
cause a significant fraction of lyso PS was lost during 
the lipid extraction procedure. This was calculated to be 
about 70% based on data obtained after complete deg- 
radation of ghost lipids (not shown). In all experiments, 
lysis of the vesicles did not exceed 2.5% during the 
incubation time. 
3.2.2. Open ghosts 
A first series of control experiments was performed 
with open white ghosts to assess the relative rate and the 
extent of degradation by PLA2 for the phospholipids of
the red blood cell membrane. As shown in Fig. 2, all 
glycerophospholipids were degraded by more than 95% 
within 15 min, reflecting very high reaction rates with 
all phospholipids, although the degradation of PS ap- 
peared to be slightly slower than that of PC and PE. 
3.2.3. Sonicated vesicles 
A second series of control experiments was per- 
formed to examine to what extend bee venom PLA2 was 
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Fig. 2. Time course of phospholipid egradation i open white ghosts. 
Phospholipase incubations were performed as described in Section 2. 
The plots show the time dependence of the degradations of PC (panel 
A), PE (panel B) and PS (panel C). 
able to hydrolyze the different phospholipids ina mem- 
brane system similar to the vesicles, but with all 
phospholipids randomized across both monolayers of 
the membrane. To obtain such a system, a vesicle sus- 
pension was sonicated for 12 min (80 W, 50% duty 
cycle) using a Branson tip sonifier. Subsequently the 
suspension was treated with PLA2 under the same con- 
ditions as described for intact vesicles. 
The results summarized in Fig. 3 show that 69% of 
PC, 54% of PE and 50% of PS were degraded after an 
incubation time of 10 min. This initial phase of rapid 
degradation was followed by a second phase with 
slower degradation rates. Even if the reaction did not 
go to completion during a 3 h incubation period the 
results till confirm that all vesicle glycerophospholipids 
are susceptible to PLA 2 action. 
3.2.4. Intact cells 
For comparison with earlier work, control experi- 
ments were also carried out with intact red blood cells. 
Degradation was complete within 1 h and reached (cor- 
rected for the amount of lysophospholipid present in 
untreated cells) 64 + 2.5% for PC, and 8.6 _+ 3.6% for 
PE (n=8) while no PS degradation could be observed, 
which is in close agreement with previous tudies (data 
not shown). Hemolysis never exceeded 2%. 
3.3. Prothrombin converting activity 
The prothrombinase assay was used as a second 
method for the characterization f PS asymmetry. The 
results ummarized in Table II show that the prothrom- 
binase activity obtained with intact vesicles is consider- 
ably higher (19-fold) than with intact red blood cells. On 
the other hand, the ratio of activities obtained with 
intact and sonicated structures i low tbr both red cells 
and vesicles. The activity in presence of sonicated vesi- 
cles was only 55% of the value in presence of sonicated 
cells. 
4. DISCUSSION 
DMPC-induced vesicles are very similar to red blood 
cells in their composition with respect to phospholipids 
and integral membrane proteins, but they are com- 
pletely devoid of spectrin [17]. They can therefore be 
considered as a membrane model system without an 
intact membrane skeleton and have been used in the 
present study to give insight into the mechanism by 
which phospholipid asymmetry is maintained. Transbi- 
layer distribution of the endogenous phospholipids of 
the vesicles was assessed by two different, independent 
approaches, namely by use of phospholipase A 2 and by 
use of the prothrombinase assay. 
The results of the experiments carried out with PLA2 
(Fig. 1) show a similar phospholipid egradation pat- 
tern for DMPC-induced vesicles and red blood cells. It 
has been shown that in an intact membrane system, 
PLA2 is able to hydrolyse primarily the phospholipid of 
the outer membrane monolayer. Hence, the fraction of 
degraded phospholipid corresponds to the fraction of 
phospholipid located in that leaflet. This would suggest 
that the steady-state ransbilayer distribution of en- 
dogenous phospholipids i  comparable in the erythro- 
cyte and vesicle membrane. 
However, several aspects of phospholipid egrada- 
tion have to be considered. PLA2 has been widely used 
as a tool to study phospholipid asymmetry in various 
membrane systems, and the potential as well as the 
pitfalls of the assay have been described extensively 
[2,27]. It is well known, that phosphotipases from vari- 
ous sources have different substrate specificities which 
might provoke incorrect interpretations of degradation 
experiments. To account for this possibility, open 
ghosts, in which phospholipids from both membrane 
leaflets are accessible to degradation, were treated with 
bee venom PLAz. The degradation patterns (Fig. 2) 
confirmed that the enzyme was able to hydrotyse the 
glycerophospholipids of the erythrocyte membrane at 
Table II 
Prothrombinase activities obtained with red blood cells and DMPC- 
induced vesicles expressed as nM formed thrombin per min per / tM 
total phospholipid 
Prothrombinase activity lntacffsonicated 
Intact Sonicated Ratio 
Erythrocytes 0.96 +_ 0.17 1505 -+ 384 
(n = 4) (n = 5) 
Vesicles 18.2 + 3.2 824 _+ 179 
(n = 3) (n = 2) 
0.064% 
2.2% 
Assays were performed as described in Section 2. The value 'n' corre- 
sponds to the number of different cell or vesicle populations. For each 
population up to 30 individual measurements were performed to 
achieve the mean value _+ S.D. shown in the table. 
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comparable rates with 95% of total PS converted within 
only 15 min. This makes it appear unlikely that the low 
amount of this lipid degraded in DMPC-induced vesi- 
cles is due to a poor specificity of the enzyme for this 
particular substrate. 
Furthermore, phospholipase activity is also depend- 
ent on the packing density of lipids in the membrane 
[28,29], which means that phospholipid hydrolysis rates 
in ghosts and intact vesicles are not necessarily compa- 
rable. Therefore, vesicles were sonicated to scramble the 
phospholipids across the bilayer before treatment with 
bee venom PLA2. The observed egradation patterns 
(Fig. 3) show in the first place that all glycerophospho- 
lipids species can be degraded in the sonicated struc- 
tures and the extent of degradation point at a more 
symmetric distribution due to the sonication of the ves- 
icles. Furthermore, the biphasic degradation behavior 
suggests a fast degradation of the readily accessible 
outer monolayer phospholipids within approximately 
10 min, followed by a slower degradation of the 
phospholipids originally located at the inner mono- 
layer, that become accessible to the enzyme by lipid 
transbilayer movement or by disintegration f the vesi- 
cles. The extent of degradation after 10 min (69% for 
PC, 54% for PE and 50% for PS) can be explained by 
the observation that sonicated vesicles have an unequal 
distribution of phospholipids across outer and inner 
monolayer, with up to 70% of the lipids of these small 
vesicles located in the outer monolayer [30] due to pack- 
ing constraints induced by the strong curvature. 
Taken together, the considerations made above 
strongly suggest that the steady-state ransbilayer dis- 
position of the phospholipids in DMPC-induced vesi- 
cles closely corresponds to their distribution in intact 
red blood celt membranes. As in the intact red cells, 
more than 56% of the PC but only some 9% of PE and 
less than 5% of PS could be degraded by PLA> after 
completion of the reaction. This would reflect a localiz- 
ation of PC primarily in the outer layer and of PE and 
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Fig. 3. Time course of phospholipid egradation in DMPC-induced 
vesicles after sonication. Phospholipase incubations were carried out 
as described in Section 2. The plots show the time dependence of the 
degradations of  PC (panel A), PE (panel B), and PS (panel C). 
The observation of an essentially maintained asym- 
metry with a slightly increased exposure of PS on the 
outer monolayer of the vesicles is further confirmed by 
the results obtained with the prothrombinase assay. The 
prothrombin converting activity of the coagulation fac- 
tors Va and Xa is supposed to be promoted by 
phospholipids and in particular by PS. In various tud- 
ies it has been shown that exposure of PS on the surface 
of platelet or red cell membranes results in an increased 
prothrombinase activity [26,31] which makes it fair to 
assume that prothrombinase activity reflects exposure 
of PS on the outer monolayer of an intact membrane 
system. According to the results hown in Table II, the 
exposure of PS on the outer monolayer of DMPC-in- 
duced vesicles is increased with respect to intact erythro- 
cytes. The percent ratio of the activities measured with 
intact and sonicated vesicles (2.2%) however points at 
a still considerably asymmetrical phospholipid distribu- 
tion. To allow an estimation of the relative amount of 
PS located at the exterior side of the membrane, it has 
to be assumed that sonicated cells expose about 70% of 
their phospholipid on the outer monolayer because of 
the curvature of the small vesMes [30]. Comparing the 
prothrombin converting activities measured in presence 
of intact and sonicated cells, it can be estimated that the 
relative amount of PS in the outer monolayer of intact 
red blood cell membranes does not exceed 0.05% of the 
total PS fraction. A raise in activity expressed per total 
phospholipid as was found with intact vesicles would, 
according to this calculation, still reveal an asymmetric 
distribution with only about 0.85% PS exposed on the 
outer monolayer. On the other hand, prothrombinase 
activity was significantly lower with sonicated vesicles 
than with sonicates cells. Because no difference was 
found in the relative content of PS between cells and 
vesicles (see Table I), this is must be either due to a 
difference in vesicle size or in the extent of phospholipid 
scrambling after sonication. Based on the phospholip- 
ase degradation ofsonicated vesicles, it can be assumed 
that in sonicated vesicles maximally 50% PS is located 
in the outer monolayer. Thus, comparing the prothrom- 
binase activities in presence of intact and sonicated ves- 
icles, the fraction of PS exposed on the outer leaflet 
would be approximately 1.1%. Note, that values in this 
order of magnitude are just around the detection limit 
of the phospholipase assay. 
Several factors can contribute to the observed slightly 
increased exposure of PS in vesicles. First, some of the 
vesicles have been shown to be fragmented (2.5%, see 
Section 3) with possibly both membrane layers accessi- 
ble to phospholipase and to the coagulation factors of 
the prothrombinase assay. Second, the increased acces- 
sibility of PS may originate from an increased transbi- 
layer mobility, due the absence of a membrane skeleton 
[9,32] with a concomitant destabilization f the bilayer. 
Furthermore, the changed composition of the vesicle 
membrane with respect o the cholesterol to phospho- 
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lipid ratio and DMPC-content  might affect membrane 
fluidity and lipid packing [33,34] which in turn may 
affect PS mobility [35] and accessibility. 
Finally, a scrambling of  phospholipids has been sug- 
gested to occur at the fusion sites during vesicle budding 
[3,36,37]. In spite of  the fact that an aminophospholipid 
translocating activity has been demonstrated in DMPC- 
induced vesicles by use of  spin-labelled phospholipid 
ana'log'ues [18], it is not known at what rate the en- 
dogenous PS can be transported back to the inner mon- 
olayer. It appears from the present study that a (small) 
fraction of  PS remains exposed in the outer monolayer, 
which might be correlated to the low ATP content o f  the 
vesicles. 
In conclusion, the two methods by which phospho- 
lipid asymmetry was determined are in perfect agree- 
ment and the results presented in this study show a 
significant asymmetry in aminophospholipid distribu- 
tion in spectrin-free vesicles derived from red blood cell 
membranes by incubation with DMPC.  Together with 
the data of  other authors [12,13] the present study sug- 
gest that asymmetry is preserved in vesicles in spite of  
the absence of  major parts of  the membrane skeleton. 
The finding is further supported by observations made 
on red cells where spectrin was either denatured or par- 
tially absent [10,11]. 
Vesicle membrane phospholipid asymmetry is main- 
tained in spite of  a destabilization of  the membrane that 
is reflected by a slightly increased exposure of  PS at the 
outer monolayer, possibly due to a somewhat increased 
transbilayer mobility of  all phospholipids in the vesicles. 
It is well possible, that in vesicles the aminophospho- 
lipid translocase helps to maintain the asymmetrical 
distribution. In view of  the low ATP content o f  the 
vesicles, however, it has to be considered that additional 
factors may support phospholipid asymmetry in vivo. 
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